Navigation Links
Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries

Grifols welcomes Los Angeles Mayor Antonio Villaraigosa, Cal State LA President James Rosser, Councilman Hose Huizar, patient representatives and other dignitaries for the construction dedication ceremony of its new IVIG facility.

LOS ANGELES, Jan. 13 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, Grifols welcomes Los Angeles Mayor Antonio Villaraigosa., Cal State LA President James Rosser, Councilman Jose Huizar and other elected officials, patient representatives and dignitaries for the ceremonial dedication of its new IVIG facility. Grifols, a global healthcare company based in Barcelona, Spain, recently broke ground on a new 92,000 square foot, intravenous immune globulin (IVIG) production facility at its US headquarters in East Los Angeles. This new facility is the initial realization of its $600 million long-range investment plan announced in October 2007 to increase production for Grifols lifesaving therapies.

The new facility represents a $135 million investment in its facility in El Sereno and will provide approximately 300 new high-paying jobs to Los Angeles. "We are committed to growing Grifols operations in Los Angeles and to giving back to the community through the creation of new quality jobs and economic growth" said Gregory Rich, President of Grifols, Inc.

"Without the support of Mayor Villaraigosa and his business team, we would not have been able to make our vision a reality in Los Angeles. This is the first step in our long-range growth plans for Los Angeles and to meet increasing patient needs for lifesaving plasma therapies."

"The bio-med industry is a critical component of the economic engine of Los Angeles and I am pleased to support Grifols expansion and investment in our great city. As the bio-med sector continues to grow, it will provide good, high-wage jobs for Angelinos. I am glad that we were instrumental in supporting Grifols expansion and allowing them to double their production capacity for their lifesaving therapies" said Mayor Antonio R. Villaraigosa.

"We commend Grifols' increased commitment to the production of immune globulin therapy. Assuring continued access to this lifesaving medicine means countless people who live with primary immunodeficiencies, such as my son, can lead healthy and productive lives," said Marcia Boyle, President and Founder of the Immune Deficiency Foundation, the national patient organization for persons with primary immune diseases.

Demand for IVIG has seen steady growth over the past ten years in the US, Europe and other international markets. The dedication ceremony took place at Grifols' US production campus and US corporate offices at 2410 Lillyvale, Los Angeles on Tuesday, January 13, 2009 at 11:00 a.m. This unique event brought together elected officials, representatives from national patient organizations, and Grifols officials to celebrate the company's efforts to ensure continued access to life-saving plasma medicines including IVIG.

About Grifols

Grifols SA (Grifols) is a global healthcare company founded in 1940 in Barcelona, Spain. Today Grifols products and services are provided in more than 90 countries around the world. Grifols specializes in the production of plasma therapies to treat a variety of life-threatening diseases and conditions. Grifols operates 80 plasma donor centers throughout the US and has manufacturing facilities located in Barcelona, Spain and Los Angeles, California. For more information about Grifols please visit or contact:

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
2. Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
3. Glaucoma Research Foundation Celebrates National Glaucoma Awareness Month
4. Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary
5. Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support
6. Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday by Placing First in Arizona Ironman Competition
7. Cloned Canine Celebrates Her 1st Birthday
8. Blue Shield of California Celebrates Completion of New Lodi Campus
9. Tenegar Town Celebrates Dedication Of New Clinic As Beacon Of Hope
10. Florida's Natural Celebrates 75 Years with Record Performance
11. Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion ... off of their purchase of lice treatment product. In addition, customers will receive a ... company spokesperson. “Finding lice is a sure way to ruin the holidays, so we ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... progress through sharing, the 2016 Building Better Radiology Marketing Programs meeting ... begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in ... for mental health and wellness consultation, has collaborated with a leading web-based marketplace ... knowledge gap experienced by parents and bring advice from parenting experts within their ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Avid collector, Andrew ... Arbor Michigan boxing style concert posters. This is one of Joplin's most famous and ... House at the University of Michigan in Ann Arbor. The According to Hawley, "It ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Japanese therapeutic drug monitoring market, including ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
Breaking Medicine Technology: